Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
4basebio Plc | 4BB | May 3, 2024 | 1 096.00 | +0.09 |
Avacta Group Plc | AVCT | May 3, 2024 | 45.12 | -2.97 |
Bioventix Plc | BVXP | May 3, 2024 | 4 325.00 | -0.12 |
C4X Discovery Holdings plc | C4XD | May 3, 2024 | 9.75 | 0.00 |
Destiny Pharma | DEST | May 3, 2024 | 18.39 | 0.00 |
Diaceutics Plc | DXRX | May 3, 2024 | 98.00 | -1.65 |
E-Therapeutics Plc | ETX | May 3, 2024 | 9.25 | -3.65 |
Evgen Pharma Plc | EVG | May 3, 2024 | 0.82 | 0.00 |
Fusion Antibodies Plc | FAB | May 3, 2024 | 3.38 | -3.43 |
Futura Medical | FUM | May 3, 2024 | 36.80 | +8.24 |
Hemogenyx Pharmaceuticals Plc | HEMO | May 3, 2024 | 1.60 | +2.43 |
HUTCHMED (China) Limited | HCM | May 3, 2024 | 310.00 | 0.00 |
Immupharma Plc | IMM | May 3, 2024 | 2.00 | -3.29 |
Ixico Plc | IXI | May 3, 2024 | 8.18 | +2.25 |
NetScientific plc | NSCI | May 3, 2024 | 61.80 | +0.64 |
Nuformix plc | NFX | May 3, 2024 | 0.18 | -1.65 |
Oncimmune Holdings plc | ONC | May 3, 2024 | 25.40 | +1.12 |
OptiBiotix Health plc | OPTI | May 3, 2024 | 18.11 | +1.69 |
Ovoca Bio Plc | OVB | May 3, 2024 | 0.79 | 0.00 |
Oxford BioDynamics plc | OBD | May 3, 2024 | 8.00 | -1.23 |
Oxford Biomedica | OXB | May 3, 2024 | 324.84 | +8.88 |
Physiomics | PYC | May 3, 2024 | 1.23 | -12.07 |
PureTech Health Plc | PRTC | May 3, 2024 | 222.97 | +3.98 |
Redx Pharma Plc | REDX | May 3, 2024 | 16.00 | 0.00 |
Reneuron Group | RENE | May 3, 2024 | 3.27 | 0.00 |
Sareum Holdings Plc | SAR | May 3, 2024 | 24.25 | -3.39 |
Scancell Hldgs Plc | SCLP | May 3, 2024 | 9.15 | -0.76 |
SkinBioTherapeutics Plc | SBTX | May 3, 2024 | 9.02 | +0.20 |
Synairgen | SNG | May 3, 2024 | 6.20 | -1.74 |
Tissue Regenix Group Plc | TRX | May 3, 2024 | 61.30 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.